Dr. Patrick R. Bergevin MD

Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...

Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...

Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...

Where would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...

Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...